Janus Henderson Group Plc

13F Holdings History for Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

Symbol: TVTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 10.6M shares
Security Ownership: 11.9%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX)

2025-11-14 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.6M shares of Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX). This represents 11.9% percent ownership of the company. In their previous filing dated 2025-08-07, JANUS HENDERSON GROUP PLC had reported owning 11.3M shares, indicating a decrease of -6.53% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JANUS HENDERSON GROUP PLC	11.9%	-6.92%	$253M	10.6M	-740,204	-6.53%	$23.90	13G/A	9/30/2025	14 Nov 2025 12:49:52
JANUS HENDERSON GROUP PLC	12.8%	+47.8%	$243M	11.3M	+3,772,901	+49.9%	$21.41	13G/A	7/31/2025	7 Aug 2025 10:34:33
JANUS HENDERSON GROUP PLC	8.5%		$102M	7.57M			$13.49	13G	3/31/2025	14 May 2025 11:48:48

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.12%	+0.01%	$253M	10.6M	+1,058,390	+11.1%	$23.90	Q3 2025
6/30/2025	0.07%	+0.01%	$141M	9.54M	+2,012,648	+26.7%	$14.80	Q2 2025
3/31/2025	0.08%	+0.04%	$148M	7.53M	+3,469,990		$19.67	Q1 2025
12/31/2024	0.04%	+0.04%	$70.7M	4.06M	+4,026,819	+12658%	$17.42	Q4 2024
9/30/2024	0%		$445K	31.8K			$13.98	Q3 2024
6/30/2024	0%	0%	$261K	31.8K	-368	-1.14%	$8.21	Q2 2024
3/31/2024	0%		$248K	32.2K	+1	+0%	$7.70	Q1 2024
12/31/2023	0%		$289K	32.2K	-55	-0.17%	$8.98	Q4 2023
9/30/2023	0%	-0.04%	$288K	32.2K	-6,934,735	-99.5%	$8.94	Q3 2023
6/30/2023	0.07%	+0%	$107M	6.97M	+121,157	+1.77%	$15.36	Q2 2023
3/31/2023	0.1%	+0.03%	$154M	6.85M	+1,754,528	+34.5%	$22.49	Q1 2023
12/31/2022	0.08%	+0.02%	$107M	5.09M	+1,178,800	+30.1%	$21.03	Q4 2022
9/30/2022	0.07%	0%	$96.4M	3.91M	-126,146	-3.12%	$24.64	Q3 2022
6/30/2022	0.07%	0%	$97.9M	4.04M	-113,416	-2.73%	$24.23	Q2 2022
3/31/2022	0.05%	+0%	$107M	4.15M	+135,889	+3.38%	$25.77	Q1 2022
12/31/2021	0.05%	0%	$125M	4.02M	-6,916	-0.17%	$31.04	Q4 2021
9/30/2021	0.04%	+0%	$97.6M	4.02M	+117,961	+3.02%	$24.25	Q3 2021
6/30/2021	0.02%	0%	$57M	3.91M	-245,443	-5.91%	$14.59	Q2 2021
3/31/2021	0.05%	+0%	$104M	4.15M	+67,003	+1.64%	$24.97	Q1 2021
12/31/2020	0.05%	+0.05%	$111M	4.08M	+4,083,553	NEW	$27.25	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.